XTLB CIK: 1023549

XTL Biopharmaceuticals Ltd. ADR

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
0
FY23:
0
FY24:
0.00
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.03
FY22:
−0.88
FY23:
−0.77
FY24:
−2.17
FY25:
−1.69
(positive)
Change from FY21 to FY23
millions USD
FY21:
−2.51
FY22:
−0.85
FY23:
−0.73
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.44
FY22:
−1.35
FY23:
−1.78
FY24:
−1.16
FY25:
−0.76
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.44
FY22:
−1.35
FY23:
−1.78
FY24:
−1.03
FY25:
−6.97

All amounts in millions USD Data sources:SEC EDGARTwelve Data